Thomas J. Schall
2019
In 2019, Thomas J. Schall earned a total compensation of $3.3M as President and Chief Executive Officer at ChemoCentryx.
Compensation breakdown
| Non-Equity Incentive Plan | $321,732 |
|---|---|
| Option Awards | $1,601,697 |
| Salary | $643,463 |
| Stock Awards | $771,400 |
| Other | $3,564 |
| Total | $3,341,856 |
Schall received $1.6M in option awards, accounting for 48% of the total pay in 2019.
Schall also received $321.7K in non-equity incentive plan, $643.5K in salary, $771.4K in stock awards and $3.6K in other compensation.
Rankings
In 2019, Thomas J. Schall's compensation ranked 3,660th out of 13,971 executives tracked by ExecPay. In other words, Schall earned more than 73.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,660 out of 13,971 | 74th |
Division Manufacturing | 1,324 out of 5,701 | 77th |
Major group Chemicals And Allied Products | 459 out of 2,200 | 79th |
Industry group Drugs | 385 out of 1,886 | 80th |
Industry Pharmaceutical Preparations | 289 out of 1,398 | 79th |
Source: SEC filing on April 5, 2022.
Schall's colleagues
We found two more compensation records of executives who worked with Thomas J. Schall at ChemoCentryx in 2019.